BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 2022. [PMID: 34988937 DOI: 10.1007/s42770-021-00675-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Shatila M, Thomas AS. Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection. JCM 2022;11:5086. [DOI: 10.3390/jcm11175086] [Reference Citation Analysis]
2 Shao Y, Lin Y, Wang B, Miao M, Ye G. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021. Helicobacter 2022;:e12920. [PMID: 35939548 DOI: 10.1111/hel.12920] [Reference Citation Analysis]
3 Arteaga-Resendiz NK, Rodea GE, Ribas-Aparicio RM, Olivares-Cervantes AL, Castelán-Vega JA, Olivares-Trejo JJ, Mendoza-Elizalde S, López-Villegas EO, Colín C, Aguilar-Rodea P, Reyes-López A, Salazar García M, Velázquez-Guadarrama N. HP0953 - hypothetical virulence factor overexpresion and localization during Helicobacter pylori infection of gastric epithelium. World J Gastroenterol 2022; 28(29): 3886-3902 [DOI: 10.3748/wjg.v28.i29.3886] [Reference Citation Analysis]
4 Villalva M, Silvan JM, Guerrero-hurtado E, Gutierrez-docio A, Navarro del Hierro J, Alarcón-cavero T, Prodanov M, Martin D, Martinez-rodriguez AJ. Influence of In Vitro Gastric Digestion of Olive Leaf Extracts on Their Bioactive Properties against H. pylori. Foods 2022;11:1832. [DOI: 10.3390/foods11131832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zheng W, Zhu Z, Ying J, Long G, Chen B, Peng K, Li F, Zhao H, Jiang M. The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer. Front Microbiol 2022;13:853184. [PMID: 35547124 DOI: 10.3389/fmicb.2022.853184] [Reference Citation Analysis]
6 Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol 2022;13:868225. [DOI: 10.3389/fimmu.2022.868225] [Reference Citation Analysis]
7 Gonciarz W, Tomaszewska A, Krupa A, Rechciński T, Chałubiński M, Broncel M, Chmiela M. Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease. JCM 2022;11:2545. [DOI: 10.3390/jcm11092545] [Reference Citation Analysis]
8 Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Brasil-costa I, Souza CDO, Monteiro LCR, Santos MES, Oliveira EHCD, Burbano RMR. H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil. Pathogens 2022;11:414. [DOI: 10.3390/pathogens11040414] [Reference Citation Analysis]
10 Akahoshi DT, Bevins CL. Flagella at the Host-Microbe Interface: Key Functions Intersect With Redundant Responses. Front Immunol 2022;13:828758. [DOI: 10.3389/fimmu.2022.828758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lai Y, Wei W, Du Y, Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes 2022;14:2120747. [PMID: 36070564 DOI: 10.1080/19490976.2022.2120747] [Reference Citation Analysis]